AURKA, aurora kinase A, 6790

N. diseases: 245; N. variants: 15
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1302401
Disease: Adenoma of large intestine
Adenoma of large intestine
0.030 Biomarker disease BEFREE AURKA gene is associated with progressive colorectal adenomas but is uninvolved in the development of nonprogressive adenomas. 25596657 2015
CUI: C1302401
Disease: Adenoma of large intestine
Adenoma of large intestine
0.030 AlteredExpression disease BEFREE Chromosome 20q DNA copy number status correlated significantly with TPX2 and AURKA protein levels in a series of colorectal adenomas and carcinomas. 22207630 2012
CUI: C1302401
Disease: Adenoma of large intestine
Adenoma of large intestine
0.030 Biomarker disease BEFREE AURKA and DSN1 are thus critical for chromosome 20q amplification-associated malignant transformation in CRA. 27329586 2016
CUI: C0279629
Disease: Adult Acute Monoblastic Leukemia
Adult Acute Monoblastic Leukemia
0.010 AlteredExpression disease BEFREE Segmental amplification of MLL gene associated with high expression of AURKA and AURKB genes in a case of acute monoblastic leukemia with complex karyotype. 20303016 2010
CUI: C0220615
Disease: Adult Acute Myeloblastic Leukemia
Adult Acute Myeloblastic Leukemia
0.010 Biomarker disease BEFREE Long non-coding RNA taurine-upregulated gene 1 correlates with poor prognosis, induces cell proliferation, and represses cell apoptosis via targeting aurora kinase A in adult acute myeloid leukemia. 29654398 2018
CUI: C0278878
Disease: Adult Glioblastoma
Adult Glioblastoma
0.080 Biomarker disease BEFREE Inhibition of AURKA suppressed glioblastoma cell growth. 20593995 2010
CUI: C0278878
Disease: Adult Glioblastoma
Adult Glioblastoma
0.080 Biomarker disease BEFREE BET and Aurora Kinase A inhibitors synergize against MYCN-positive human glioblastoma cells. 31754113 2019
CUI: C0278878
Disease: Adult Glioblastoma
Adult Glioblastoma
0.080 Biomarker disease BEFREE In conclusion, our results demonstrated that miR-124 inhibited glioblastoma growth and potentiated chemosensitivity by targeting AURKA, which may represent promising targets and rational therapeutic options for glioblastoma. 28242198 2017
CUI: C0278878
Disease: Adult Glioblastoma
Adult Glioblastoma
0.080 AlteredExpression disease BEFREE The AURKA inhibitor alisertib exhibits antiproliferative activity against glioblastoma in vitro and in vivo. 29396807 2018
CUI: C0278878
Disease: Adult Glioblastoma
Adult Glioblastoma
0.080 Biomarker disease BEFREE AURKA kinase inhibition could effectively attenuate Wnt signaling, thereby inhibiting the self-renewal and tumorigenicity of GICs, and may be a novel target for glioblastoma treatment strategies. 23761169 2013
CUI: C0278878
Disease: Adult Glioblastoma
Adult Glioblastoma
0.080 AlteredExpression disease BEFREE Differential expression of those genes was detected between human normal glial cells and glioblastoma cells by quantitative reverse transcription polymerase chain reaction (P < 0.05), and the survival curve analysis showed that the patients with low expression of gene AURKA, NDC80, KIF4A, and NUSAP1 had a significant favorable prognosis (P < 0.05). 28989042 2018
CUI: C0278878
Disease: Adult Glioblastoma
Adult Glioblastoma
0.080 Biomarker disease BEFREE We show that AURKA and KDR genes are hub driver genes in glioblastoma with bioinformatics technology including WGCNA analysis, PPI network, GO, KEGG analysis and GSEA analysis. 31706255 2019
CUI: C0278878
Disease: Adult Glioblastoma
Adult Glioblastoma
0.080 Biomarker disease BEFREE We have previously shown that the selective AURKA inhibitor alisertib potently inhibits growth of glioblastoma cells. 31011934 2019
CUI: C0278608
Disease: Adult Liposarcoma
Adult Liposarcoma
0.020 Biomarker disease BEFREE Overall, our study showed that selinexor treatment restored tumor suppressive function of IGFBP5 and inhibited aurora kinase A and B in liposarcoma cells supporting the usefulness of selinexor as a potential therapeutic strategy for the treatment of this cancer. 27893412 2017
CUI: C0278608
Disease: Adult Liposarcoma
Adult Liposarcoma
0.020 Biomarker disease BEFREE Expression profile‑driven discovery of AURKA as a treatment target for liposarcoma. 31485600 2019
CUI: C0220630
Disease: Adult Liver Carcinoma
Adult Liver Carcinoma
0.020 Biomarker disease BEFREE A MYC-aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer. 27213815 2016
CUI: C0220630
Disease: Adult Liver Carcinoma
Adult Liver Carcinoma
0.020 GeneticVariation disease BEFREE This HCC marker set contained several cancer-related genes, including serine/threonine kinase 15 (STK15), which has been implicated in chromosome segregation abnormalities but which has not been linked previously with liver cancer. 12591738 2003
Adult Malignant Peripheral Nerve Sheath Tumor
0.010 Biomarker disease BEFREE Ras-driven transcriptome analysis identifies aurora kinase A as a potential malignant peripheral nerve sheath tumor therapeutic target. 22811580 2012
CUI: C0278876
Disease: Adult Medulloblastoma
Adult Medulloblastoma
0.010 Biomarker disease BEFREE Microarray-based screening for molecular markers in medulloblastoma revealed STK15 as independent predictor for survival. 15126347 2004
CUI: C3900098
Disease: Adult Myelodysplastic Syndrome
Adult Myelodysplastic Syndrome
0.010 AlteredExpression disease BEFREE Differential expression of AURKA and AURKB genes in bone marrow stromal mesenchymal cells of myelodysplastic syndrome: correlation with G-banding analysis and FISH. 23092930 2013
CUI: C0220605
Disease: Adult Non-Hodgkin Lymphoma
Adult Non-Hodgkin Lymphoma
0.020 AlteredExpression disease BEFREE These results suggest that Aurora2/BTAK/STK15 is an effective candidate to indicate not only disease activity but also tumorigenesis of non-Hodgkin's lymphoma. 12716366 2003
CUI: C0220605
Disease: Adult Non-Hodgkin Lymphoma
Adult Non-Hodgkin Lymphoma
0.020 Biomarker disease BEFREE A novel Aurora kinase A inhibitor MK-8745 predicts TPX2 as a therapeutic biomarker in non-Hodgkin lymphoma cell lines. 21879811 2012
CUI: C4524268
Disease: Advanced lung cancer
Advanced lung cancer
0.010 GeneticVariation disease BEFREE Prospective assessment of XRCC3, XPD and Aurora kinase A single-nucleotide polymorphisms in advanced lung cancer. 23053267 2012
CUI: C4725076
Disease: Advanced Urothelial Carcinoma
Advanced Urothelial Carcinoma
0.010 GeneticVariation disease BEFREE Association of an aurora kinase a (AURKA) gene polymorphism with progression-free survival in patients with advanced urothelial carcinoma treated with the selective aurora kinase a inhibitor alisertib. 28155045 2017
Aggressive Adult Non-Hodgkin Lymphoma
0.010 Biomarker disease BEFREE Aurora2/BTAK/STK15 is involved in cell cycle checkpoint and cell survival of aggressive non-Hodgkin's lymphoma. 12716366 2003